Randomized trial demonstrates enhanced accuracy in detecting tumor-derived extracellular vesicles for cancer diagnosis, indicating potential in clinical settings.
Key Points
The study aims to enhance the accuracy and selectivity of single extracellular vesicle (EV) analysis for cancer diagnostics.
Developed protocols for single-EV analysis to reduce false positives and improve assay robustness.
Optimized EV labeling and colocalization analysis with cancer-specific markers.
Validated the approach using fluorescence imaging and nanoflow cytometry on tumor-derived EVs in plasma samples.
Enhanced detection accuracy of tumor-derived EVs, achieving consistent results across both imaging methods and significantly reducing false positives.